GLPGF

Galapagos NV (GM) Stock Price

79.50
-2.25 (-2.75%)
79.50

Low
75.00

52 Week Range

High
223.00

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Small Cap Pro
Monthly Subscription
for only
$49.05
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
VAT not included
Company Name Stock Ticker Symbol Market Type
Galapagos NV (GM) GLPGF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-2.25 -2.75% 79.50 14:21:59
Open Price Low Price High Price Close Price Prev Close
79.50 79.50 79.50 79.50 81.75
Bid Price Ask Price Spread News
81.75 81.75 0.00 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1 12 $ 79.50 $ 954 - 75.00 - 223.00
Last Trade Time Type Quantity Stock Price Currency
14:21:59 12 $ 79.50 USD

Galapagos NV (GM) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.13B 26.77M - $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
138.84k $ - 0.00% - -

more financials information »

Galapagos NV (GM) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GLPGF Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week78.0081.7578.0079.63231.501.92%
1 Month75.0081.7575.0076.382,3334.506.0%
3 Months107.00110.1075.0093.844,399-27.50-25.7%
6 Months130.4898130.489875.0098.906,426-50.99-39.08%
1 Year212.00223.0075.00100.254,014-132.50-62.5%
3 Years98.50276.2175.00152.624,955-19.00-19.29%
5 Years41.63276.2141.63128.364,99737.8790.97%

Galapagos NV (GM) Description

Galapagos is a midsized biotechnology company, with therapeutic programs based on proprietary disease modifying drug targets, and a focus on inflammation, orphan disease, and anti-infectives. Galapagos' approach is to develop drugs that stop or reverse a disease state using novel targets that are identified through a patent protected target discovery platform. Galapagos also provides access to its target and drug discovery platform through its services division, BioFocus and Argenta, which offers a full suite of target-to-drug discovery products and services to pharmaceutical and biotech companies.


Your Recent History
USOTC
GLPGF
Galapagos ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.